Operators as Investors: Scaling Healthcare Platforms

In a market where allocators are increasingly focused on healthcare innovation, growth equity discipline, and the role of operators in driving outcomes, this episode sits directly at the intersection.

This conversation with Sal DeTrane of Empactful Capital extends a theme we’ve been hearing consistently from CIOs, OCIOs, and allocators across the Dakota Live platform: the next wave of value creation in private markets is being driven by execution, not just access.

Sal brings that lens into focus.

With a background that spans venture, investment banking, and hands-on operating leadership, he represents an important cohort of operators-turned-investors, those who don’t just underwrite businesses but help build them.

We explore how that perspective is being applied inside one of the most complex and opportunity-rich sectors in the market today: healthcare technology.

What We Cover:

• Why allocators are leaning into healthcare tech now
  From value-based care to behavioral health integration, we unpack the structural tailwinds driving sustained interest and capital flows into the space.
• Growth equity through an operator’s lens
  How Empactful approaches the critical $5–$20M revenue inflection point (where many companies stall) and what it actually takes to scale.
• Platforms vs. point solutions
  Why scalable healthcare businesses must move beyond single-use cases and into integrated, defensible platforms.
• The reality of scaling healthcare companies
  Long sales cycles, complex stakeholders, and reimbursement dynamics—and how disciplined execution bridges the gap.
• Operators as investors
  What changes when the investor has been the CFO, COO, or CEO—and why that matters to both founders and LPs.
• Alignment with allocator priorities
  Liquidity timelines, DPI focus, and disciplined capital deployment—directly addressing the concerns we continue to hear across the allocator community

Why This Episode Matters:

For listeners, this is a chance to better understand the increasingly blurred line between venture and growth equity—and what it actually looks like in practice when you combine venture upside with growth equity discipline.

For operators and founders, it’s a clear articulation of what sophisticated capital expects today:
milestone-driven execution, commercial traction, and the ability to scale with precision.

And for anyone following the broader private markets conversation, this episode builds on a theme we’ve been hearing repeatedly:it’s not just where capital is going—but how it behaves once it gets there, and who is responsible for turning it into outcomes